MeroGel Injectable Bioresorbable Nasal Packing and Sinus Stent
Indications
MeroGel® Injectable Bioresorbable Stent is indicated for use in the middle ear and external ear canal following canalplasty, myringoplasty, tympanoplasty, and stapes and mastoid surgery. The device is indicated following nasal/sinus surgery or trauma to prevent lateralization of the middle turbinate and nasal adhesions during the post operative period.
Contraindications
MeroGel Injectable is contraindicated in patients with a known hypersensitivity to hyaluronan or its derivatives.
Warnings and Precautions
In rare instances, the physiochemical condition associated with sinus surgery, both with and without sinus packing, may present a risk of toxic shock syndrome (TSS). Warning signs of TSS include: sudden fever, vomiting, diarrhea, dizziness, fainting (or near fainting when standing up), and/or a rash that looks like a sunburn. MeroGel Injectable exhibits no antimicrobial properties; it is not bacteriostatic toward pre-existing infections, nor does it prevent the occurrence of new infections.
Do not inject intravascularly.
Foreign body reaction may occur as with most surgical adjuvant treatments. MeroGel Injectable must be used according to the instructions for use. Read instructions prior to use.